KSHV alteration of cellular metabolism
KSHV 改变细胞代谢
基本信息
- 批准号:8845429
- 负责人:
- 金额:$ 34.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-12-16 至 2019-11-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAfricaCancer EtiologyCarbonCell ProliferationCell SurvivalCell physiologyCellsCitric Acid CycleClinical TrialsCommon NeoplasmDataDeveloping CountriesEndothelial CellsEndotheliumEnvironmentFatty AcidsGlucoseGlutamineHerpesviridaeHerpesviridae InfectionsHuman Herpesvirus 8Kaposi SarcomaLesionLytic PhaseMaintenanceMetabolicMetabolic PathwayMetabolismMorbidity - disease rateOncogenic VirusesOpportunistic InfectionsPathologicPathway interactionsPatientsPentosephosphate PathwayPharmaceutical PreparationsPublishingReportingSpindle Cell NeoplasmTherapeuticTherapeutic InterventionViralVirusaerobic glycolysisbasecancer cellcell typeglucose metabolismglucose uptakeinhibitor/antagonistkillingslatent infectionmetabolic abnormality assessmentmortalityneoplastic cellnew therapeutic targetnovelpublic health relevancetherapeutic targettumortumorigenesisuptake
项目摘要
DESCRIPTION (provided by applicant):
Opportunistic infections are a major cause of morbidity and mortality of AIDS patients in developing countries and AIDS patients are susceptible to a number of cancers caused by opportunistic infections. Kaposi's Sarcoma (KS) is the most common tumor of AIDS patients and is the most commonly reported tumor overall in parts of Africa. The etiologic agent of KS is Kaposi's Sarcoma-associated herpesvirus (KSHV or HHV-8). KSHV is invariably found in the main KS tumor cell, the spindle cell, a cell of endothelial origin and is predominantly found in th latent state. There are no drugs to target latent infection of herpesviruses. Therefore, an important therapeutic approach is to delineate and target host endothelial cell processes required for KSHV latency. Recent studies have shown that pathologic changes in cell metabolism can be a driver of oncogenesis rather than simply an adaptation to the tumor environment. While a few studies have examined alterations of cellular metabolism during lytic infection of viruses, we were the first to examine changes in cellular metabolism during latent infection. We demonstrated that latent KSHV infection of endothelial cells leads to an alteration in glucose carbon utilization, specifically inducing aerobic glycolysis. Importantly, we found that
KSHV induction of aerobic glycolysis is essential for the survival of latently infected cells. Our preliminary data for this proposal show that latent KSHV infection also induces glutamine uptake and requires glutamine for the survival of latently infected cells. Therefore, altered utilization f both glucose and glutamine, are critical for the maintenance of KSHV latency. In this proposal, we will examine how glucose and glutamine are utilized specifically in endothelial cells latently infected with KSHV, the relevant cell type for KS tumors. In the first aim we will analyze glucose metabolism during latent infection to further identify how glucose carbons are metabolized and why these alterations are needed for the survival of latent infection. We will also examine the cellular and viral mechanisms for induction of altered glucose utilization. In the second aim we will analyze the cellular and viral mechanism of increased glutamine uptake and determine how glutamine is metabolized during latent infection. Our data indicate that pathologic changes in cellular metabolism induced by KSHV could provide novel therapeutic targets for latently infected cells and would ultimately provide therapeutic targets for KS tumors in AIDS patients.
描述(由申请人提供):
机会性感染是发展中国家艾滋病患者发病和死亡的主要原因,艾滋病患者易患由机会性感染引起的多种癌症,卡波西肉瘤(KS)是艾滋病患者最常见的肿瘤,也是最常报道的。 KS 的病原体是卡波西肉瘤相关疱疹病毒(KSHV 或 HHV-8),主要存在于非洲部分地区。 KS 肿瘤细胞,梭形细胞,一种内皮来源的细胞,主要处于潜伏状态。目前还没有针对疱疹病毒潜伏感染的药物,因此,一种重要的治疗方法是确定和靶向宿主内皮细胞过程。 KSHV 潜伏期。最近的研究表明,细胞代谢的病理变化可能是肿瘤发生的驱动因素,而不仅仅是对肿瘤环境的适应,而一些研究已经检查了细胞裂解感染期间细胞代谢的变化。病毒,我们是第一个检查潜伏感染期间细胞代谢变化的人,我们证明内皮细胞的潜伏 KSHV 感染会导致葡萄糖碳利用率的改变,从而诱导有氧糖酵解。
KSHV 诱导有氧糖酵解对于潜伏感染细胞的生存至关重要,我们的初步数据表明,潜伏 KSHV 感染也会诱导谷氨酰胺摄取,并且需要谷氨酰胺来维持潜伏感染细胞的生存。对于维持 KSHV 潜伏期至关重要。在本提案中,我们将研究如何在潜伏感染 KSHV 的内皮细胞中专门利用葡萄糖和谷氨酰胺,这是相关的。第一个目标是分析潜伏感染期间的葡萄糖代谢,以进一步确定葡萄糖碳的代谢方式以及为什么这些改变对于潜伏感染的存活是必需的。我们还将检查诱导的细胞和病毒机制。在第二个目标中,我们将分析谷氨酰胺摄取增加的细胞和病毒机制,并确定潜伏感染期间谷氨酰胺的代谢方式。我们的数据表明,KSHV 引起的细胞代谢的病理变化可以为治疗提供新的靶点。潜伏感染的细胞,最终将为艾滋病患者的 KS 肿瘤提供治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Lagunoff其他文献
Michael Lagunoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Lagunoff', 18)}}的其他基金
Cellular Requirements for KSHV Latency in Endothelial Cells
内皮细胞对 KSHV 潜伏期的细胞要求
- 批准号:
9980822 - 财政年份:2019
- 资助金额:
$ 34.52万 - 项目类别:
KSHV immortalization of human lymphatic endothelial cells
KSHV 人淋巴内皮细胞永生化
- 批准号:
10328906 - 财政年份:2018
- 资助金额:
$ 34.52万 - 项目类别:
KSHV immortalization of human lymphatic endothelial cells
KSHV 人淋巴内皮细胞永生化
- 批准号:
10088333 - 财政年份:2018
- 资助金额:
$ 34.52万 - 项目类别:
相似国自然基金
非洲猪瘟病毒关键抗原表位筛选和功能验证
- 批准号:32302858
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非洲猪瘟病毒pS273R通过切割G3BP1调控宿主应激颗粒形成的机制
- 批准号:32302893
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非洲猪瘟病毒B475L蛋白靶向LMP2抑制抗原递呈的分子机制
- 批准号:32302894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于非洲猪瘟病毒pS273R蛋白泛素-蛋白酶体降解途径阻抑机制理性设计其特异性蛋白水解靶向嵌合体的研究
- 批准号:32373044
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自噬在呋虫胺致非洲爪蟾脂质代谢紊乱中的调控机制研究
- 批准号:42307363
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
- 批准号:
10763054 - 财政年份:2023
- 资助金额:
$ 34.52万 - 项目类别:
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
生物衰老对赞比亚艾滋病毒感染者免疫相关宫颈癌结果差异的影响
- 批准号:
10754783 - 财政年份:2023
- 资助金额:
$ 34.52万 - 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
- 批准号:
10754981 - 财政年份:2023
- 资助金额:
$ 34.52万 - 项目类别:
The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV
AVANÇO 研究联盟:莫桑比克/巴西/德克萨斯州联盟,旨在推进新颖且负担得起的技术,用于预防和诊断艾滋病毒感染妇女的宫颈癌
- 批准号:
10598934 - 财政年份:2023
- 资助金额:
$ 34.52万 - 项目类别: